238 related articles for article (PubMed ID: 35418162)
21. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma.
Shang C; Tang W; Pan C; Hu X; Hong Y
Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407
[TBL] [Abstract][Full Text] [Related]
22. PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.
Yang E; Wang L; Jin W; Liu X; Wang Q; Wu Y; Tan Y; Wang Y; Cui X; Zhao J; Tong F; Hong B; Xiao M; Liu X; Fang C; Kang C
Theranostics; 2022; 12(9):4330-4347. PubMed ID: 35673568
[No Abstract] [Full Text] [Related]
23. PSMG3-AS1 enhances glioma resistance to temozolomide via stabilizing c-Myc in the nucleus.
Zhou L; Huang X; Zhang Y; Wang J; Li H; Huang H
Brain Behav; 2022 May; 12(5):e2531. PubMed ID: 35380741
[TBL] [Abstract][Full Text] [Related]
24. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
25. ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression.
Yang JT; Lee IN; Huang C; Huang HC; Wu YP; Chong ZY; Chen JC
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175410
[TBL] [Abstract][Full Text] [Related]
26. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.
Wei Y; Lu C; Zhou P; Zhao L; Lyu X; Yin J; Shi Z; You Y
Neuro Oncol; 2021 Apr; 23(4):611-624. PubMed ID: 32926734
[TBL] [Abstract][Full Text] [Related]
27. Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response.
Panzarini E; Tacconi S; Carata E; Mariano S; Tata AM; Dini L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171763
[TBL] [Abstract][Full Text] [Related]
28. Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regulates Temozolomide Resistance by miR-519a-3p/RRM1 Axis in Glioblastoma.
Yuan Z; Yang Z; Li W; Wu A; Su Z; Jiang B
Cancer Biother Radiopharm; 2020 Jul; ():. PubMed ID: 32721218
[No Abstract] [Full Text] [Related]
29. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
31. LncRNA HOXA-AS2 Promotes Temozolomide Resistance in Glioblastoma by Regulated miR-302a-3p/IGF1 Axis.
Lin L; Lin D; Jin L; Wang J; Lin Z; Zhang S; Lin G
Genet Res (Camb); 2022; 2022():3941952. PubMed ID: 36479381
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma.
Liu B; Zhou J; Wang C; Chi Y; Wei Q; Fu Z; Lian C; Huang Q; Liao C; Yang Z; Zeng H; Xu N; Guo H
Cell Death Dis; 2020 May; 11(5):384. PubMed ID: 32439916
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis.
Bi CL; Liu JF; Zhang MY; Lan S; Yang ZY; Fang JS
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057597
[TBL] [Abstract][Full Text] [Related]
34. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Hellmold D; Kubelt C; Daunke T; Beckinger S; Janssen O; Hauck M; Schütt F; Adelung R; Lucius R; Haag J; Sebens S; Synowitz M; Held-Feindt J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240419
[TBL] [Abstract][Full Text] [Related]
35. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis.
Ling Z; Zhang J; Liu Q
Bioengineered; 2022 Mar; 13(3):6012-6023. PubMed ID: 35191808
[TBL] [Abstract][Full Text] [Related]
37. MIR99AHG/miR-204-5p/TXNIP/Nrf2/ARE Signaling Pathway Decreases Glioblastoma Temozolomide Sensitivity.
Zhou L; Ma J
Neurotox Res; 2022 Oct; 40(5):1152-1162. PubMed ID: 35904670
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
Tian T; Mingyi M; Qiu X; Qiu Y
Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
[TBL] [Abstract][Full Text] [Related]
39. Implication of lncRNA ZBED3-AS1 downregulation in acquired resistance to Temozolomide and glycolysis in glioblastoma.
Dong J; Peng Y; Zhong M; Xie Z; Jiang Z; Wang K; Wu Y
Eur J Pharmacol; 2023 Jan; 938():175444. PubMed ID: 36462734
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
